Related Experiment Videos
Physicochemical and genetic evidence for specific antiestrogen binding sites
Summary
Antiestrogens tamoxifen and 4-hydroxytamoxifen bind to distinct antiestrogen binding sites (ABS) in cells, separate from the estrogen receptor (ER). Loss of ABS correlates with tamoxifen resistance, suggesting ABS involvement in antiestrogen action.
Area of Science:
- Endocrinology
- Molecular Pharmacology
- Cancer Biology
Background:
- Antiestrogens like tamoxifen (Tam) and 4-hydroxytamoxifen (OH-Tam) exhibit complex biological activities.
- These compounds interact with both the estrogen receptor (ER) and other cellular components.
Purpose of the Study:
- To investigate the nature and function of antiestrogen binding sites (ABS).
- To determine the relationship between ABS and cellular responses to antiestrogens, particularly tamoxifen resistance.
Main Methods:
- Binding studies using radiolabeled antiestrogens in rat uterus and human breast cancer MCF-7 cell cytosol.
- Physical separation of ABS from ER using bioaffinity adsorbents and heparin-Sepharose chromatography.
- Sucrose gradient ultracentrifugation to analyze ABS heterogeneity.
- Comparison of ABS presence in tamoxifen-sensitive (MCF-7) and tamoxifen-resistant (RTx6) cell lines.
Main Results:
- ABS were identified and physically separated from ER, with distinct binding affinities for Tam and OH-Tam.
- ABS concentration was 10-20% of ER concentration, with a dissociation constant (Kd) of 1-2 x 10(-9) M for Tam and OH-Tam.
- ABS exhibited heterogeneous sedimentation patterns (10-40 S) and were unaffected by conditions altering ER.
- Tamoxifen-resistant RTx6 cells showed a significant lack of detectable ABS compared to sensitive MCF-7 cells.
Conclusions:
- ABS represent a distinct binding entity in cells, separate from the ER.
- The presence of ABS appears crucial for the antiestrogenic effects of tamoxifen and related compounds.
- The absence of ABS in resistant cells suggests their critical role in mediating tamoxifen sensitivity and action.